A Simple Blood Test To Monitor Asbestos-related Cancer

The Mesomark Assay test kit was developed by Fujirebio Diagnostics to measure levels of a biomarker called SMRP in serum. Biomarkers are substances found in higher-than-normal concentrations in the blood, urine or body tissues of patients with certain diseases.

"Current diagnostic tests are less than ideal for identifying changes in tumor volume, which is key to managing this aggressive disease," Dr. Allard adds. "As the Mesomark results correlate with tumor volume, it provides a much-needed tool for monitoring patient status."

To learn more, visit www.fdi.com/mesomark. A First-A simple blood test may now enable doctors to monitor an asbestos-related cancer.

Article Source: http://www.thearticleinsiders.com